The incidence of inflammatory bowel disease (IBD) is rapidly rising throughout the world.
Although tremendous efforts have been made, limited therapeutics are available for IBD …

Inflammatory bowel disease (IBD), which mainly consists of Crohn's disease and ulcerative
colitis, is a chronic and relapsing inflammatory condition of the gastrointestinal tract. The …

Inflammatory bowel disease (IBD) is a group of disorders that cause chronic non-specific
inflammation in the gastrointestinal (GI) tract, primarily affecting the ileum and colon. The …

As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …

Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are highly
debilitating. IBDs are associated with the imbalance of inflammatory mediators within the …

Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory
Bowel Disease (IBD). However, they all are implicated in causing severe side effects and …

Inflammatory bowel disease (IBD) is a chronic recurrent intestinal disease. The incidence
rate of IBD is increasing year by year, which seriously endangers human health worldwide …

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is characterized by chronic relapsing inflammation of the gastrointestinal tract. Delivery …

Colon targeted drug delivery is an active area of research for local diseases affecting the
colon, as it improves the efficacy of therapeutics and enables localized treatment, which …

Treatments for inflammatory bowel disease (IBD) are typically immunosuppressive. Despite
a range of treatment options, limited efficacy, systemic toxicities like bone marrow …